JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Inventory | 6.33%235.66M | -12.67%211.11M | 16.61%221.64M | 18.81%241.75M | -10.68%190.07M | -17.30%203.48M | 3.37%212.78M | 36.11%246.03M | 32.46%205.84M | 22.10%180.76M |
Accounts receivable | -25.64%295.78M | -20.07%322M | 29.97%397.76M | 16.17%402.85M | -10.63%306.04M | 4.85%346.78M | 10.88%342.42M | -10.85%330.75M | -14.64%308.81M | 6.98%370.99M |
Advance deposits and other receivables | 337.47%463.93M | 16.01%120.4M | 90.96%106.05M | 28.78%103.78M | -1.42%55.54M | 102.69%80.59M | -46.91%56.34M | -78.64%39.76M | -59.24%106.11M | -51.11%186.14M |
Cash and equivalents | 52.78%1.13B | 11.60%905.83M | 23.20%741.15M | 40.49%811.68M | 5.20%601.58M | -20.96%577.74M | 6.56%571.82M | 55.05%730.99M | 20.71%536.61M | -26.95%471.46M |
Financial assets at fair value-current assets | -46.29%102.86M | -11.30%160.87M | -25.00%191.5M | -12.89%181.36M | 79.17%255.33M | 3.48%208.18M | -70.09%142.51M | -60.23%201.19M | 16.65%476.4M | 167.08%505.83M |
Special items of current assets | ---- | ---- | -93.19%2.58M | -97.27%2.58M | -75.16%37.86M | --94.26M | --152.39M | ---- | ---- | ---- |
Total current assets | 34.32%2.23B | -1.36%1.72B | 14.81%1.66B | 15.42%1.74B | -2.15%1.45B | -2.43%1.51B | -9.52%1.48B | -9.71%1.55B | 0.20%1.63B | 0.28%1.72B |
Non-current assets | ||||||||||
Property, plant and equipment | 62.75%1.04B | 9.02%758.91M | 58.49%640.02M | 95.03%696.12M | 8.34%403.82M | -21.14%356.93M | -18.84%372.72M | -2.21%452.59M | -1.99%459.24M | -4.82%462.83M |
Investment property | --2.68M | --2.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Construction in progress | -81.01%88.08M | -27.92%356.9M | -31.16%463.73M | -26.67%495.14M | 119.40%673.67M | 229.68%675.2M | 804.01%307.05M | 660.08%204.8M | 156.34%33.97M | 154.87%26.95M |
Advance payment | 0.00%7.56M | 0.00%7.56M | --7.56M | -47.31%7.56M | ---- | -28.22%14.36M | ---- | --20M | ---- | ---- |
Associated company interest | ---- | ---- | -92.44%5.05M | -70.95%25.35M | -18.14%66.76M | -11.57%87.25M | -24.13%81.55M | 27.41%98.67M | 28.33%107.48M | 161.63%77.44M |
Financial assets at fair value-non-current assets | --20M | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Intangible assets | 2.68%303.11M | -2.28%288.31M | 3.61%295.21M | 2.79%295.03M | 9.44%284.94M | 38.84%287.01M | 32.73%260.37M | 38.12%206.72M | 57.70%196.16M | 134.93%149.66M |
Goodwill | 0.00%241.16M | 0.00%241.16M | 0.00%241.16M | 0.00%241.16M | 0.00%241.16M | 0.00%241.16M | 0.00%241.16M | 0.00%241.16M | 0.00%241.16M | --241.16M |
Deferred tax assets | -83.06%3.46M | 176.63%18.98M | 226.07%20.42M | 19.33%6.86M | -7.49%6.26M | -11.95%5.75M | 23.66%6.77M | -1.72%6.53M | -25.07%5.47M | 14.08%6.64M |
Total non-current assets | -4.36%1.81B | -1.36%1.9B | 3.20%1.9B | 5.48%1.93B | 32.67%1.84B | 34.94%1.83B | 18.20%1.39B | 26.50%1.36B | 14.64%1.17B | 63.37%1.07B |
Total assets | 13.70%4.04B | -1.36%3.62B | 8.31%3.56B | 9.97%3.67B | 14.69%3.28B | 15.01%3.34B | 2.06%2.86B | 4.21%2.9B | 5.77%2.81B | 17.77%2.79B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | 15.35%189.42M | -27.63%162.16M | 51.01%164.21M | 56.46%224.07M | 0.16%108.74M | -9.14%143.21M | -29.09%108.56M | 0.54%157.61M | 7.57%153.09M | 20.20%156.76M |
Tax payable | -72.49%14.44M | 422.84%45.23M | 163.84%52.48M | -44.19%8.65M | 112.58%19.89M | 66.70%15.5M | -23.88%9.36M | 60.04%9.3M | -6.77%12.29M | -70.87%5.81M |
Other payables and accrued expenses | -31.59%268.08M | -33.90%341.13M | 7.81%391.88M | 5.21%516.07M | 32.20%363.48M | 57.18%490.52M | 49.59%274.95M | 30.08%312.07M | -1.00%183.81M | 41.31%239.91M |
Bank loans and overdrafts | 464.48%182.55M | 1,766.02%120.06M | 33.13%32.34M | -69.38%6.43M | 162.76%24.29M | --21.01M | -91.85%9.25M | ---- | -42.55%113.4M | --216.78M |
Derivative financial instrument-current liabilities | ---- | ---- | ---- | --474K | ---- | ---- | ---- | ---- | ---- | ---- |
Financial lease liabilities-current liabilities | 37.30%1.37M | -76.27%364K | -3.19%1M | 56.53%1.53M | 12.90%1.03M | 6.06%980K | 82.27%915K | 1,300.00%924K | --502K | --66K |
Other current liabilities | ---- | ---- | ---- | 575.52%174.82M | --25.88M | --25.88M | ---- | ---- | ---- | ---- |
Total current liabilities | 2.17%655.85M | -28.23%668.94M | 18.15%641.91M | 33.70%932.06M | 34.81%543.32M | 45.26%697.1M | -12.97%403.03M | -22.51%479.91M | -14.01%463.09M | 93.46%619.32M |
Net current assets | 54.57%1.57B | 29.47%1.05B | 12.81%1.02B | -0.24%811.94M | -16.01%903.08M | -23.85%813.93M | -8.15%1.08B | -2.47%1.07B | 7.21%1.17B | -21.17%1.1B |
Total assets less current liabilities | 16.23%3.39B | 7.78%2.95B | 6.37%2.92B | 3.71%2.74B | 11.40%2.74B | 9.02%2.64B | 5.03%2.46B | 11.85%2.42B | 10.80%2.34B | 5.92%2.17B |
Non-current liabilities | ||||||||||
Financial lease liabilities-non-current liabilities | 3,591.15%4.17M | -76.80%103K | -88.64%113K | -70.92%444K | -38.31%995K | -24.59%1.53M | -33.35%1.61M | -28.72%2.03M | -9.02%2.42M | --2.84M |
Deferred tax liability | 1.87%102.92M | 4.90%94.38M | 36.74%101.03M | 34.55%89.98M | 26.19%73.88M | 8.35%66.87M | -3.04%58.55M | -7.16%61.72M | -6.14%60.38M | 25.45%66.47M |
Other non-current liabilities | --10.5M | ---- | ---- | ---- | -0.08%175.46M | 0.00%175.6M | 0.00%175.6M | 150.00%175.6M | 150.00%175.6M | 0.00%70.24M |
Special items of non-current liabilities | ---- | ---- | -49.17%305K | -50.00%300K | -33.33%600K | -33.33%600K | -25.00%900K | -25.00%900K | -20.42%1.2M | -20.42%1.2M |
Total non-current liabilities | 15.91%117.59M | 4.15%94.49M | -59.57%101.45M | -62.91%90.72M | 6.04%250.94M | 1.81%244.59M | -1.23%236.65M | 70.68%240.24M | 72.70%239.6M | 12.84%140.75M |
Total liabilities | 4.05%773.44M | -25.36%763.43M | -6.41%743.35M | 8.61%1.02B | 24.16%794.25M | 30.77%941.7M | -8.97%639.68M | -5.25%720.14M | 3.75%702.69M | 70.85%760.08M |
Total assets less total liabilities | 16.24%3.27B | 7.90%2.86B | 13.01%2.81B | 10.51%2.65B | 11.97%2.49B | 9.81%2.4B | 5.74%2.22B | 7.76%2.18B | 6.46%2.1B | 5.47%2.03B |
Total equity and non-current liabilities | 16.23%3.39B | 7.78%2.95B | 6.37%2.92B | 3.71%2.74B | 11.40%2.74B | 9.02%2.64B | 5.03%2.46B | 11.85%2.42B | 10.80%2.34B | 5.92%2.17B |
Equity | ||||||||||
Share capital | 0.04%80.46M | 0.08%80.46M | 0.06%80.43M | 0.02%80.39M | 0.09%80.38M | -0.87%80.37M | -2.77%80.31M | -2.17%81.07M | -1.89%82.61M | -1.58%82.87M |
Reserve | 16.87%3.19B | 8.30%2.77B | 14.01%2.73B | 11.36%2.56B | 12.49%2.39B | 10.07%2.3B | 5.96%2.13B | 7.56%2.09B | 6.09%2.01B | 5.77%1.94B |
Shareholders' Equity | 16.39%3.27B | 8.05%2.85B | 13.55%2.81B | 10.97%2.64B | 12.04%2.47B | 9.68%2.38B | 5.62%2.21B | 7.15%2.17B | 5.77%2.09B | 5.44%2.03B |
Non-controlling interest | -49.27%3.12M | -42.13%4.58M | -64.53%6.14M | -53.86%7.91M | 2.27%17.31M | 31.00%17.15M | 25.05%16.93M | 1,836.24%13.09M | --13.54M | --676K |
Total equity | 16.24%3.27B | 7.90%2.86B | 13.01%2.81B | 10.51%2.65B | 11.97%2.49B | 9.81%2.4B | 5.74%2.22B | 7.76%2.18B | 6.46%2.1B | 5.47%2.03B |
Total equity and total liabilities | 13.70%4.04B | -1.36%3.62B | 8.31%3.56B | 9.97%3.67B | 14.69%3.28B | 15.01%3.34B | 2.06%2.86B | 4.21%2.9B | 5.77%2.81B | 17.77%2.79B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.